Skip to main content
. 2022 Mar 20;25(3):137–146. doi: 10.3779/j.issn.1009-3419.2022.101.07

Table 2.

Adverse reaction spectrum of UGT1A1*6 and UGT1A1*28

Adverse reaction UGT1A1*6 P UGT1A1*28 P
WT (n=64) HM (n=43) WT (n=81) HM (n=26)
Vomit grade 0.020 0.013
  0 30 (46.88%) 16 (37.21%) 41 (50.62%) 5 (19.23%)
  1-2 25 (39.06%) 11 (25.58%) 25 (30.86%) 11 (42.31%)
  3-4 9 (14.06%) 16 (37.21%) 15 (18.52%) 10 (38.46%)
Mucositis 0.322 0.005
  Yes 46 (71.88%) 27 (62.79%) 61 (75.31%) 12 (46.15%)
  No 18 (28.12%) 16 (37.21%) 20 (24.69%) 14 (53.85%)
Diarrhea grade 0.027 0.382
  0-2 50 (78.12%) 25 (58.14%) 55 (67.90%) 20 (76.92%)
  3-4 14 (21.88%) 18 (41.86%) 26 (32.10%) 6 (23.08%)
Neutropenia grade 0.005 0.241
  0-2 43 (67.19%) 17 (39.53%) 48 (59.26%) 12 (46.15%)
  3-4 21 (32.81%) 26 (60.47%) 33 (40.74%) 14 (53.85%)
Anemia 0.654 0.820
  Yes 53 (82.81%) 37 (86.05%) 69 (85.19%) 21 (80.77%)
  No 11 (17.19%) 6 (13.95%) 12 (14.81%) 5 (19.23%)
Thrombocytopenia 0.481 0.510
  Yes 54 (84.38%) 34 (79.07%) 65 (80.25%) 23 (88.46%)
  No 10 (15.62%) 9 (20.93%) 16 (19.75%) 3 (11.54%)
Fatigue 0.654 0.697
  Yes 53 (82.81%) 37 (86.05%) 67 (82.72%) 23 (88.46%)
  No 11 (17.19%) 6 (13.95%) 14 (17.28%) 3 (11.54%)